Clinical Study on Responder Prediction in Cardiac Resynchronization Therapy Using Individual Molecular Measurement of Natriuretic Peptide
Not Applicable
Recruiting
- Conditions
- Patients with cardiac resynchronization therapy (CRT)
- Registration Number
- JPRN-UMIN000034148
- Lead Sponsor
- ational Cerebral and Cardiovascular Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with serum creatinine level equal or over 1.5 mg/dl, dialysis, and who judged to be ineligible for participation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Deaths from any cause and heart failure admissions
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of natriuretic peptides predict CRT response in heart failure patients?
How does natriuretic peptide profiling compare to standard methods in predicting CRT effectiveness?
Which biomarkers in natriuretic peptide levels correlate with CRT success in patients with heart failure?
Are there CRT-related adverse events linked to baseline natriuretic peptide levels in observational studies?
Can ARNI therapy improve CRT outcomes when combined with individual peptide measurements?